Cardiac Cachexia

Cardiac cachexia is a syndrome associated with the progressive loss of muscle and fat mass. It most commonly affects patients with heart failure and can significantly decrease the quality of life and survival in these patients. Here is the latest research on cardiac cachexia.

December 6, 2021
Review

Exercise training in heart transplantation.

World Journal of Transplantation
Christos KourekStavros Dimopoulos
December 6, 2021
Open Access

Pharmacological Inhibition of HMGB1 Prevents Muscle Wasting.

Frontiers in Pharmacology
Lu LiShiying Yu
December 6, 2021

Cancer and malnutrition were independently associated with a poor prognosis in patients with heart failure.

Journal of cardiology
Satoru MiyanagaMichihiro Yoshimura
December 6, 2021
Open Access

MMP12 knockout prevents weight and muscle loss in tumor-bearing mice.

BMC Cancer
Lingbi JiangJiangchao Li
December 5, 2021

The prevalence of CT-defined low skeletal muscle mass in patients with metastatic cancer: a cross-sectional multicenter French study (the SCAN study).

Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
Bruno RaynardFrançois Goldwasser
December 4, 2021

Alantolactone ameliorates cancer cachexia-associated muscle atrophy mainly by inhibiting the STAT3 signaling pathway.

Phytomedicine : International Journal of Phytotherapy and Phytopharmacology
Qiang ShenXuan Liu
December 4, 2021

Cysteine 253 of UCP1 regulates energy expenditure and sex-dependent adipose tissue inflammation.

Cell Metabolism
Evanna L MillsEdward T Chouchani
December 3, 2021
Review

From quiescence to repair: C/EBPβ as a regulator of muscle stem cell function in health and disease.

The FEBS Journal
Hamood AlSudais, Nadine Wiper-Bergeron
December 3, 2021
Case Report

Rare complication of West Nile viral encephalitis.

Ideggyógyászati szemle
Péter FaragóJános Tajti
December 2, 2021

The Management of Cancer Symptoms and Treatment-Induced Side Effects With Cannabis or Cannabinoids.

Journal of the National Cancer Institute. Monographs
Michelle SextonMark S Wallace
December 2, 2021

Cannabinoids and Cancer Chemotherapy-Associated Adverse Effects.

Journal of the National Cancer Institute. Monographs
Sara Jane WardLinda A Parker
December 2, 2021
Review

Microproteins in skeletal muscle: hidden keys in muscle physiology.

Journal of Cachexia, Sarcopenia and Muscle
Bernardo Bonilauri, Bruno Dallagiovanna
December 2, 2021

Effects of canagliflozin versus finerenone on cardiorenal outcomes: exploratory post-hoc analyses from FIDELIO-DKD compared to reported CREDENCE results.

Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association
Rajiv AgarwalGeorge L Bakris
December 1, 2021

Study and Detection of Citrus Viroids in Woody Hosts.

Methods in Molecular Biology
Robert R Krueger, Georgios Vidalakis
December 1, 2021

Pectoralis major muscle quantification by cardiac MRI is a strong predictor of major events in HF.

Heart and Vessels
Gonçalo J L CunhaAntónio M Ferreira
November 30, 2021

Multi-targeted therapy of cancer by omega-3 fatty acids-an update.

Cancer Letters
Lengyun WeiYong Q Chen

Sign up to follow this feed and discover related papers.

Related Feeds

22q11 Deletion Syndrome

22q11.2 deletion syndrome, also known as DiGeorge syndrome, is a congenital disorder caused by a partial deletion of chromosome 22. Symptoms include heart defects, poor immune system function, a cleft palate, complications related to low levels of calcium in the blood, and delayed development. Discover the latest research on this disease here.

Alagille Syndrome

Alagille syndrome is a multi-system genetic disorder that can affect the liver, heart, and other parts of the body. It’s characterization includes heart problems, liver damage, jaundice, and xanthomas. Here is the latest research.

Aneurysm

Aneurysms are outward distensions or bulges that occurs in a weakened wall of blood vessels. Discover the latest research on aneurysms here.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Aortic Aneurysm

An aortic aneurysm is the weakening and bulging of the blood vessel wall in the aorta. This causes dilatation of the aorta, which is usually asymptomatic but carries the risk of rupture and hemorrhage. Find the latest research on aortic aneurysms here.

Aortic Coarctation

Aortic coarctation is a congenital condition characterized by narrowing of the aorta. Discover the latest research on this disease here.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Arrhythmogenic Right Ventricular Dysplasia

Arrhythmogenic right ventricular dysplasia is a congenital cardiomyopathy that is characterized by infiltration of adipose and fibrous tissue into the right ventricle wall and loss of myocardial cells. Primary injuries usually are at the free wall of the right ventricular and right atria resulting in ventricular and supraventricular arrhythmias. Discover the latest research on arrhythmogenic right ventricular dysplasia here.

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

© 2021 Meta ULC. All rights reserved
/feed-previews/cardiac-cachexia/ac19b9fb-e44b-4701-86bf-b70272d5df25